(Allergan plc)

	AGN latest price $151.6163 (-1.99%) ($150.2904 - $156.3711) on Sun. Dec. 9, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.77% (three month average)
RSI	35
Latest Price	$151.6163(-1.99%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN declines -0.2% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   (0%)    (0%)    (0%)    (0%)    (0%)
Factors Impacting AGN price	AGN will decline at least -0.885% in a week (0% probabilities).   (0%)    (0%)    (0%)    (0%)    (0%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.885% (StdDev 1.77%)
Hourly BBV	0 ()
Intraday Trend	-2%

Resistance Level	$156.17
5 Day Moving Average	$154.51(-1.87%)
10 Day Moving Average	$153.76(-1.39%)
20 Day Moving Average	$156.17(-2.92%)
To recent high	-20.9%
To recent low	0.3%
Market Cap	$N/A

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed